Correlation Between Enzo Biochem and Neuronetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enzo Biochem and Neuronetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzo Biochem and Neuronetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzo Biochem and Neuronetics, you can compare the effects of market volatilities on Enzo Biochem and Neuronetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzo Biochem with a short position of Neuronetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzo Biochem and Neuronetics.

Diversification Opportunities for Enzo Biochem and Neuronetics

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Enzo and Neuronetics is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Enzo Biochem and Neuronetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuronetics and Enzo Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzo Biochem are associated (or correlated) with Neuronetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuronetics has no effect on the direction of Enzo Biochem i.e., Enzo Biochem and Neuronetics go up and down completely randomly.

Pair Corralation between Enzo Biochem and Neuronetics

Considering the 90-day investment horizon Enzo Biochem is expected to under-perform the Neuronetics. But the stock apears to be less risky and, when comparing its historical volatility, Enzo Biochem is 1.79 times less risky than Neuronetics. The stock trades about -0.22 of its potential returns per unit of risk. The Neuronetics is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest  100.00  in Neuronetics on November 28, 2024 and sell it today you would earn a total of  357.00  from holding Neuronetics or generate 357.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Enzo Biochem  vs.  Neuronetics

 Performance 
       Timeline  
Enzo Biochem 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Enzo Biochem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Neuronetics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neuronetics are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Neuronetics displayed solid returns over the last few months and may actually be approaching a breakup point.

Enzo Biochem and Neuronetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enzo Biochem and Neuronetics

The main advantage of trading using opposite Enzo Biochem and Neuronetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzo Biochem position performs unexpectedly, Neuronetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuronetics will offset losses from the drop in Neuronetics' long position.
The idea behind Enzo Biochem and Neuronetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data